Cappuccino mutation in an autoimmune-prone strain of mice suggests a role of platelet function in the progression of immune complex crescentic glomerulonephritis.

OBJECTIVE Crescent formation in the renal glomerulus is a typical manifestation of progressive glomerulopathy associated with fatal renal failure; therefore, its prevention is of clinical importance. Little is known about the pathogenic mechanism for crescent formation. This study was undertaken in an attempt to identify the events that are critical for crescent formation in immune complex crescentic glomerulonephritis (CGN) by analyzing a novel mutant strain of mice. METHODS A spontaneous mutant strain of mice was isolated from the autoimmune-prone strain EOD, which stably develops fatal CGN. The mutant phenotypes were assessed histopathologically, hematologically, and immunologically. The mutation was searched for with positional cloning using microsatellite markers. RESULTS Compared with wild-type EOD (WT-EOD) mice, mutant EOD (mut-EOD) mice showed marked improvement in CGN in conjunction with an improvement in spontaneous mortality. In WT-EOD mice, an inverse correlation between blood urea nitrogen concentration and blood platelet count and massive accumulation of platelets in the glomerulus were evident, suggesting that an accumulation of platelets in the glomerulus contributes to the progression of CGN. The mutant platelets showed an abnormal aggregation in response to collagen and thrombin, associated with a bleeding tendency in mut-EOD mice. Genetic analysis revealed a deleterious mutation in the cappuccino gene (cno), which encodes a protein that belongs to a complex called the biogenesis of lysosome-related organelle complex 1 and is profoundly involved in platelet function. Morphologic examination revealed a partial defect in dense body formation in the delta-granule of platelets. CONCLUSION The present findings suggest that platelet functions have a critical role in crescent formation in autoimmune GN.

[1]  W. Clark,et al.  Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. , 1975, Clinical science and molecular medicine.

[2]  T. Yoshino,et al.  Modulation of Immunoglobulin (Ig)E-mediated Systemic Anaphylaxis by Low-Affinity Fc Receptors for IgG , 1999, The Journal of experimental medicine.

[3]  John D Lambris,et al.  C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist , 2005, European journal of immunology.

[4]  B. Ryffel,et al.  Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[5]  E. C. Dell'Angelica,et al.  Identification of Snapin and Three Novel Proteins (BLOS1, BLOS2, and BLOS3/Reduced Pigmentation) as Subunits of Biogenesis of Lysosome-related Organelles Complex-1 (BLOC-1)* , 2004, Journal of Biological Chemistry.

[6]  K. Matsushima,et al.  A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. , 2000, Journal of the American Society of Nephrology : JASN.

[7]  Y. Suzuki,et al.  Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats. , 1995, Japanese journal of pharmacology.

[8]  H. Avenarius,et al.  Thrombozytenfunktion und Thrombozyten-assoziierte Immunglobuline bei Patienten mit systemischem Lupus erythematodes und chronischer Polyarthritis , 1990, Klinische Wochenschrift.

[9]  P. Tipping,et al.  IL‐12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis , 1999, European journal of immunology.

[10]  S. Fujita,et al.  Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. , 2005, Arthritis and rheumatism.

[11]  P. Ronco,et al.  Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  J. Meyerhoff,et al.  Decreased platelet serotonin levels in systemic lupus erythematosus. , 1981, Arthritis and rheumatism.

[13]  H. Watanabe,et al.  Mice with early onset of death (EOD) due to lupus glomerulonephritis , 1999, Clinical and experimental immunology.

[14]  T. Shirakawa,et al.  Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. , 2003, Kidney international.

[15]  J. Bonifacino,et al.  Reduced pigmentation (rp), a mouse model of Hermansky-Pudlak syndrome, encodes a novel component of the BLOC-1 complex. , 2004, Blood.

[16]  C. Pusey,et al.  Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. , 2005, Kidney international.

[17]  P. Carmeliet,et al.  Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis , 2001, Nature Medicine.

[18]  J. Bonifacino,et al.  Cappuccino, a mouse model of Hermansky-Pudlak syndrome, encodes a novel protein that is part of the pallidin-muted complex (BLOC-1). , 2003, Blood.

[19]  Cameron Js Glomerulonephritis: current problems and understanding. , 1982 .

[20]  M. Ono,et al.  Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. , 2000, The Journal of experimental medicine.

[21]  G. Frampton,et al.  Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus. , 1980, Clinical nephrology.

[22]  R. Atkins,et al.  Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. , 1995, Kidney international.

[23]  D. Salant,et al.  Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. , 2002, The Journal of clinical investigation.

[24]  Y. Igarashi Sarpogrelate, a serotonin receptor (5HT2ar) antagonist, ameliorates renal damage in experimental mesangial proliferative glomerulonephritis , 2000, Clinical and Experimental Nephrology.

[25]  C. Kallenberg,et al.  Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. , 1996, Kidney international.

[26]  S. Giannouli,et al.  Lupus thrombocytopenia: clinical implications and prognostic significance , 2005, Annals of the rheumatic diseases.

[27]  J. Bonifacino,et al.  Defects in the cappuccino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky-Pudlak syndrome by an AP-3-independent mechanism. , 2000, Blood.

[28]  Naoki Oiso,et al.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) , 2003, Nature Genetics.

[29]  R. Swank,et al.  Cocoa: a new mouse model for platelet storage pool deficiency , 1988, British journal of haematology.

[30]  M. Rashid,et al.  Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. , 2004, Pharmacology & therapeutics.

[31]  R. Atkins,et al.  Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid Production , 1998, Molecular medicine.

[32]  J. Miyazaki,et al.  Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. , 2003, Arthritis and rheumatism.

[33]  I. Narita,et al.  Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis 1 , 2003, The Journal of Immunology.

[34]  P. Tipping,et al.  Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. , 1998, Kidney international.

[35]  G. Frampton,et al.  Platelet and plasma serotonin concentrations in glomerulonephritis, II. , 1980, Clinical nephrology.

[36]  Stephen Tomlinson,et al.  Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. , 2003, The Journal of clinical investigation.

[37]  S. Israels,et al.  Platelet dense granules: structure, function and implications for haemostasis. , 1999, Thrombosis research.

[38]  J. Ravetch,et al.  Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.

[39]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Journal of the American Society of Nephrology : JASN.

[40]  M. Ono,et al.  Bone marrow cell transfer of autoimmune diseases in a MRL strain of mice with a deficit in functional Fas ligand: Dissociation of arteritis from glomerulonephritis , 2003, Pathology international.

[41]  J. Falcón-Pérez,et al.  BLOC-1, a Novel Complex Containing the Pallidin and Muted Proteins Involved in the Biogenesis of Melanosomes and Platelet-dense Granules* , 2002, The Journal of Biological Chemistry.

[42]  H. Hirakata,et al.  Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. , 2005, Arthritis and rheumatism.

[43]  W. Clark,et al.  Immunologic findings, thrombocytopenia and disease activity in lupus nephritis. , 1978, Canadian Medical Association journal.

[44]  K. Hiromura,et al.  Role of serotonin in nephrotoxic serum nephritis in WKY rats. , 1997, The Journal of laboratory and clinical medicine.

[45]  C. Heldin,et al.  COULD PLATELET-DERIVED GROWTH FACTOR HAVE A ROLE IN THE PATHOGENESIS OF LUPUS NEPHRITIS? , 1988, The Lancet.

[46]  P. Tipping,et al.  IFN-γ Mediates Crescent Formation and Cell-Mediated Immune Injury in Murine Glomerulonephritis , 1999 .

[47]  D. Witte,et al.  Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. , 2001, American journal of physiology. Renal physiology.

[48]  P. Tipping,et al.  Contributions of IL-1β and IL-1α to Crescentic Glomerulonephritis in Mice , 2004 .

[49]  F. Rendu,et al.  The platelet release reaction: granules' constituents, secretion and functions , 2001, Platelets.